Supplementary Table 1 from Pan-Cancer Efficacy of Vemurafenib in &lt;i&gt;BRAF&lt;/i&gt;&lt;sup&gt;V600&lt;/sup&gt;-Mutant Non-Melanoma Cancers

Vivek Subbiah; Igor Puzanov; Jean Yves Blay; Ian Chau; A. Craig Lockhart; Noopur Raje; Juergen Wolf; José Baselga; Funda Meric‐Bernstam; Jason Roszik; Eli L. Diamond; Gregory J. Riely; Eric J. Sherman; Todd Riehl; Bethany Pitcher; David M. Hyman

doi:10.1158/2159-8290.22535060

Supplementary Table 1 from Pan-Cancer Efficacy of Vemurafenib in BRAFV600-Mutant Non-Melanoma Cancers

Vivek Subbiah, Igor Puzanov, Jean Yves Blay, Ian Chau, A. Craig Lockhart, Noopur Raje, Juergen Wolf, José Baselga, Funda Meric‐Bernstam, Jason Roszik, Eli L. Diamond, Gregory J. Riely, Eric J. Sherman, Todd Riehl, Bethany Pitcher, David M. Hyman

Dataset

Supplementary Table 2 from Pan-Cancer Efficacy of Vemurafenib in BRAFV600-Mutant Non-Melanoma Cancers

Vivek Subbiah, Igor Puzanov, Jean Yves Blay, Ian Chau, A. Craig Lockhart, Noopur Raje, Juergen Wolf, José Baselga, Funda Meric‐Bernstam, Jason Roszik, Eli L. Diamond, Gregory J. Riely, Eric J. Sherman, Todd Riehl, Bethany Pitcher, David M. Hyman

Dataset

Supplementary Table 2 from Pan-Cancer Efficacy of Vemurafenib in BRAFV600-Mutant Non-Melanoma Cancers

Vivek Subbiah, Igor Puzanov, Jean Yves Blay, Ian Chau, A. Craig Lockhart, Noopur Raje, Juergen Wolf, José Baselga, Funda Meric‐Bernstam, Jason Roszik, Eli L. Diamond, Gregory J. Riely, Eric J. Sherman, Todd Riehl, Bethany Pitcher, David M. Hyman

Preprint2023

Supplementary Data from Pan-Cancer Efficacy of Vemurafenib in BRAFV600-Mutant Non-Melanoma Cancers

Vivek Subbiah, Igor Puzanov, Jean Yves Blay, Ian Chau, A. Craig Lockhart, Noopur Raje, Juergen Wolf, José Baselga, Funda Meric‐Bernstam, Jason Roszik, Eli L. Diamond, Gregory J. Riely, Eric J. Sherman, Todd Riehl, Bethany Pitcher, David M. Hyman

Preprint2023

Supplementary Data from Pan-Cancer Efficacy of Vemurafenib in BRAFV600-Mutant Non-Melanoma Cancers

Vivek Subbiah, Igor Puzanov, Jean Yves Blay, Ian Chau, A. Craig Lockhart, Noopur Raje, Juergen Wolf, José Baselga, Funda Meric‐Bernstam, Jason Roszik, Eli L. Diamond, Gregory J. Riely, Eric J. Sherman, Todd Riehl, Bethany Pitcher, David M. Hyman

Supplementary Table 1 from Pan-Cancer Efficacy of Vemurafenib in <i>BRAF</i><sup>V600</sup>-Mutant Non-Melanoma Cancers

Abstract

Discussion(0)

Related publications

Supplementary Table 1 from Pan-Cancer Efficacy of Vemurafenib in <i>BRAF</i><sup>V600</sup>-Mutant Non-Melanoma Cancers

Supplementary Table 2 from Pan-Cancer Efficacy of Vemurafenib in <i>BRAF</i><sup>V600</sup>-Mutant Non-Melanoma Cancers

Supplementary Table 2 from Pan-Cancer Efficacy of Vemurafenib in <i>BRAF</i><sup>V600</sup>-Mutant Non-Melanoma Cancers

Supplementary Data from Pan-Cancer Efficacy of Vemurafenib in <i>BRAF</i><sup>V600</sup>-Mutant Non-Melanoma Cancers

Supplementary Data from Pan-Cancer Efficacy of Vemurafenib in <i>BRAF</i><sup>V600</sup>-Mutant Non-Melanoma Cancers

Supplementary Table 1 from Pan-Cancer Efficacy of Vemurafenib in &lt;i&gt;BRAF&lt;/i&gt;&lt;sup&gt;V600&lt;/sup&gt;-Mutant Non-Melanoma Cancers

Abstract

Discussion(0)

Related publications